🏺 Pharmakon Mining - Ancient Greek Patent Discovery

Pharmakon Mining

Cross-axis patent discovery: Ancient Greek pharmacology → Modern science

Mining 2,500-year-old pharmaceutical knowledge for patentable formulations that modern pharma hasn’t touched.

---

Concept

The Ancient Greeks documented extensive pharmacological knowledge in texts that predate modern patent systems by millennia. This knowledge includes:

• Complex polypharmacy formulations (50+ ingredients)
• Preparation methods and aging protocols
• Dosing strategies including hormesis (sub-lethal exposure)
• Therapeutic applications across multiple conditions

The Gap: Modern pharmaceutical research rarely cross-references ancient texts. Formulations described in Greek sources may represent novel, patentable combinations when mapped to modern chemistry.

---

The Pharmakon Principle

φάρμακον (pharmakon) = poison AND remedy (same Greek word)

This linguistic unity encodes ancient understanding:

• Dose determines poison vs. medicine
• Healing and harming are aspects of one power
• The therapeutic window is the key insight

This maps directly to modern pharmacology’s dose-response relationships and therapeutic indices.

---

Architecture

┌─────────────────────────────────────────────────────────────┐
│                    PHARMAKON MINING                         │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│  ┌──────────────┐           ┌──────────────┐               │
│  │    GREEK     │           │  SCIENCE +   │               │
│  │   CORPUS     │ ─cross──► │  MEDICINE    │               │
│  │  (pharmakon) │  query    │   CORPORA    │               │
│  │  1,135 chunks│           │  640K+ chunks│               │
│  └──────────────┘           └──────────────┘               │
│         │                          │                        │
│         └────────────┬─────────────┘                        │
│                      ▼                                      │
│              ┌──────────────┐                               │
│              │  GAP FINDER  │                               │
│              │                                              │
│              │  Queries:                                    │
│              │  • Ancient formulation + modern chemistry?   │
│              │  • Described mechanism without patent?       │
│              │  • Synergy unexplored by pharma?            │
│              │  • Preparation method not industrialized?   │
│              └──────────────┘                               │
│                      │                                      │
│                      ▼                                      │
│              ┌──────────────┐                               │
│              │   DISCLOSURE │                               │
│              │   GENERATOR  │                               │
│              └──────────────┘                               │
│                                                             │
└─────────────────────────────────────────────────────────────┘

---

Entity Mappings

Greek → Modern Pharmacology

Greek Term	Transliteration	Modern Equivalent
φάρμακον	pharmakon	Active pharmaceutical ingredient (API)
ὕλη	hyle	Raw material / substrate
κρᾶσις	krasis	Formulation / compound
δύναμις	dynamis	Mechanism of action (MOA)
δόσις	dosis	Therapeutic dose / window
πάθος	pathos	Indication / condition
τέχνη	techne	Manufacturing process
θεραπεία	therapeia	Treatment protocol
ἀντίδοτος	antidotos	Antidote / antagonist
σύνθεσις	synthesis	Compounding method

Entity Extraction Targets

From Greek Corpus:

• Substances (plant, animal, mineral)
• Preparation methods (grinding, heating, aging, fermenting)
• Combinations (which ingredients together)
• Dosing (amounts, frequencies, durations)
• Indications (conditions treated)
• Contraindications (when NOT to use)

Cross-Reference with Modern:

• Chemical compositions of named substances
• Pharmacological mechanisms
• Modern safety/toxicology data
• Existing patents on components
• Gaps in patent coverage for combinations

---

Primary Sources

Greek Corpus (In Knowledge System)

Source	Content	Patent Potential
The Theriac	64-ingredient antidote, viper flesh, opioids	High — complex polypharmacy
Greek Magical Papyri	Ritual preparations with psychoactives	Medium — ceremonial formulations
Dioscorides	De Materia Medica — 600+ substances	Very High — systematic pharmacopeia
Galen	Theriac protocols, aging methods	High — manufacturing processes
Nicander	Theriaca, Alexipharmaca — poisons/antidotes	High — toxicology
Hippocratic Corpus	Early therapeutic protocols	Medium — treatment methods

Key Texts to Acquire

• Dioscorides — De Materia Medica (full text)
• Theophrastus — Historia Plantarum (botanical source)
• Galen — Theriac treatises (manufacturing detail)
• Nicander — Theriaca and Alexipharmaca (Loeb edition)

---

Mining Targets

Tier 1: High-Confidence Opportunities

1. Theriac Viper Peptides

Ancient: Processed viper flesh as core immunological component Modern Gap: Oral degraded venom peptides unexplored Patent Angle: Orally bioavailable venom-derived immunomodulators Prior Art Check: Snake venom patents focus on injectable, not oral degraded

2. Polypharmacy Synergy Optimization

Ancient: 64-ingredient formulations with documented effects Modern Gap: Pharma typically uses 1-2 actives; complex synergies unexplored Patent Angle: Validated multi-component formulations from ancient protocols Prior Art Check: Specific combinations likely unpatented

3. Extended Aging Chemistry

Ancient: Theriac required 12+ years aging for “full potency” Modern Gap: Fermentation/aging chemistry in pharmaceuticals underexplored Patent Angle: Time-dependent compound formation in polypharmacy Prior Art Check: Wine/cheese aging studied; pharmaceutical aging rare

4. Hormetic Dosing Protocols

Ancient: Mithridatic principle — sub-lethal toxin exposure builds tolerance Modern Gap: Microdosing protocols for toxin-derived therapeutics Patent Angle: Graduated exposure protocols for specific compounds Prior Art Check: Allergy desensitization exists; broader applications open

Tier 2: Research Required

5. Purple Dye Psychoactives

Ancient: Murex-derived purple associated with altered states Modern Gap: Brominated indoles from Murex not fully characterized Patent Angle: Novel psychoactive compounds from ancient dye sources Research Needed: Chemical analysis of Murex secretions

6. Colchian Pharmakeia

Ancient: Medea’s legendary botanical knowledge from Black Sea region Modern Gap: Pontus-region endemic plants underexplored Patent Angle: Novel alkaloids from Caucasus flora Research Needed: Ethnobotanical surveys, species identification

7. Temple Medicine Protocols

Ancient: Asclepian healing temples with documented cures Modern Gap: Combination of environment + substance + ritual Patent Angle: Therapeutic protocols (harder to patent, but possible) Research Needed: Full protocol reconstruction

---

Cross-Query Examples

Query 1: Theriac Components → Modern Chemistry

GREEK QUERY: "theriac ingredients preparation"
RETURNS: opium, viper flesh, myrrh, castoreum, 60+ components

CROSS-QUERY TO SCIENCE: 
  - "morphine receptor binding"
  - "venom peptide immunology"
  - "myrrh anti-inflammatory mechanism"
  - "castoreum salicylic acid"

GAP ANALYSIS:
  - Which combinations lack patents?
  - Which synergies are undocumented?
  - Which preparation methods are novel?

Query 2: Ancient Antidotes → Modern Toxicology

GREEK QUERY: "antidote poison treatment alexipharmaca"
RETURNS: specific antidote protocols from Nicander

CROSS-QUERY TO MEDICINE:
  - Modern antidote mechanisms
  - Existing poison treatments
  - Patent landscape for antidotes

GAP ANALYSIS:
  - Ancient antidotes without modern equivalents
  - Novel mechanisms not yet patented

---

Implementation Status

Phase 1: Foundation ✅ COMPLETE (2026-02-02)

pharmakon_miner.py — 669 lines, operational

Component	Status
Greek corpus queries	✅ Working (1,135 chunks)
Modern corpus queries	✅ Working (554K+ science, 378K+ QB)
Cross-axis querying	✅ Working
Regex entity extraction	✅ Working
Claude-powered extraction	✅ Built (optional, slower)
Gap detection via Claude	✅ Built
CLI interface	✅ Working

Baseline Test Results:

📜 theriac viper antidote polypharmacy
   Greek: 2 hits | Entities: ['aconite', 'snake', 'poison']
   Modern: 2 hits | Sources: ['science', 'science']

📜 opium poppy analgesic pain
   Greek: 2 hits | Modern: 2 hits

📜 hellebore madness psychiatric
   Greek: 2 hits | Modern: 2 hits

📜 myrrh wound antimicrobial
   Greek: 2 hits | Entities: ['fever', 'inflammation']
   Modern: 2 hits | Sources: ['quantum_biology', 'science']

Storage: ChromaDB migrated to /mnt/storage/knowledge-rag/chroma_db (3.9TB available)

Phase 2: Enrichment (Next)

• Ingest remaining Greek texts (Dioscorides priority)
• Run full --scan on priority targets
• Tune Claude CLI timeouts for gap detection
• Prior art search integration (USPTO, Google Patents)

Phase 3: Disclosure Generation

• Template for pharmakon-derived patents
• Automatic novelty scoring
• Human review workflow
• Priority ranking system

---

Success Metrics

Metric	Target
Greek entities extracted	500+ substances, 200+ methods
Cross-references identified	100+ ancient→modern mappings
Patent gaps found	20+ novel combinations
Disclosures generated	5+ per month (after Phase 2)
Provisional filings	1-2 per quarter

---

Risks & Mitigations

Risk	Mitigation
Ancient texts inaccurate	Cross-validate with multiple sources
Substances toxic/illegal	Focus on legal, safe compounds
Prior art exists	Thorough USPTO/Google Patents search
Formulations obvious	Focus on non-obvious combinations
Manufacturing infeasible	Partner with compounding pharmacies

---

Related

• PatentBot Main — Parent project
• The Theriac — Primary research source
• Greek Magical Papyri — Ritual preparations
• Knowledge Systems — RAG infrastructure
• Greek Studies — Broader context

---

Notes

The pharmakon concept itself — that the same substance is both poison and cure — is the key insight. Modern pharmacology quantifies this as the therapeutic index (lethal dose / effective dose). The Greeks understood this qualitatively; we can now map their formulations quantitatively.

The 12-year aging requirement for theriac suggests they understood that chemical transformations occur over time — fermentation, oxidation, compound formation. This is essentially ancient pharmaceutical chemistry waiting to be decoded.

---

Usage

cd ~/projects/knowledge-rag
source venv/bin/activate
 
# Query Greek corpus only
python pharmakon_miner.py --query-greek "theriac viper antidote"
 
# Query modern corpora only
python pharmakon_miner.py --query-modern "venom peptide immunology"
 
# Cross-axis query (Greek → Modern)
python pharmakon_miner.py --cross "theriac polypharmacy aging"
 
# Mine specific concept with gap detection (uses Claude)
python pharmakon_miner.py --concept "viper venom therapeutic peptide"
 
# Full scan of priority targets
python pharmakon_miner.py --scan --output pharmakon_opportunities.json
 
# Pre-configured mining targets
python pharmakon_miner.py --theriac

Code Location

• Module: ~/projects/knowledge-rag/pharmakon_miner.py
• ChromaDB: /mnt/storage/knowledge-rag/chroma_db (symlinked)
• Collections: greek_corpus, science_corpus, quantum_biology, medicine_corpus, etc.

---

“The theriac-maker works at the edge of death, compounding poisons into salvation. The line between healer and poisoner is not chemical but intentional.”

---

Created: 2026-02-02 Status: Phase 1 Complete Next Action: Ingest Dioscorides, run full scan